HIPEC vs EPIC in patients of Peritoneal Surface Malignancies

In our study, we compared the immediate surgical outcomes of HIPEC and EPIC in patients with Ovarian cancer spread to the peritoneal cavity undergoing cytoreductive surgery. This comparison can help in feasibility assessment for future prospective trials comparing the outcomes of both modalities and establishing and standardizing protocols for both the interventions. This study also helps in placing EPIC in the treatment algorithm of peritoneal surface malignancy patients if HIPEC cannot be done due to resource constraints or patient factors and along with this comparison we audited our peritoneal surface malignancies data.

Autorentext

M. D. Ray, MS, FRCS, PhD, FACS, é um eminente cirurgião oncológico, investigador molecular e professor, orientador de oncologia cirúrgica e doutorado no instituto de primeira linha, AIIMS, Nova Deli, Índia. Publicou mais de 110 artigos em revistas nacionais e internacionais e tem 14 livros de medicina e 21 livros de literatura. Acredita que a humanidade é a melhor religião.